Gene therapy screening to discover aging targets (Martin Borch Jensen - Gordian Biotechnology)

Gene therapy screening to discover aging targets (Martin Borch Jensen -  Gordian Biotechnology) Gordian Biotechnology is a San Francisco Bay Area biotech company that has created the first in vivo therapeutic screening platform aimed at drug development for complex diseases of aging. Co-founder and Chief Science Officer, Dr. Martin Borch Jensen joins the show today to discuss Gordian’s unique in vivo pooled screening in animals, as well as which indications they are targeting, their strategy to bring drugs to market, and how Gordian is currently tackling the challenges inherent to animal models. Martin also speaks about his passion from an early age to help fight age-related disease, and making the transition from academia to entrepreneurship, giving up a K99 fellowship at thehttps://www.buckinstitute.org/ ( Buck Institute for Research on Aging) to make the jump into biotech. You’ll also hear about Martin’s involvement in multiple efforts to promote longevity science and bring new people into the field, including his apprenticeship program, the newly announced Longevity Impetus Grants program, and recording his “Science of Aging” seminar. Next, Martin shares what’s next for Gordian as they get ready to scale to the next level, which areas of longevity science he is most interested in but not currently working on, and how he predicts the field will evolve over the next five to ten years. For more information on Martin’s apprenticeship program and Impetus Grants application process, please visit https://www.martinborchjensen.com/apprenticeship (MartinBorchJensen.com) or follow him on https://twitter.com/MartinBJensen (Twitter). Episode Highlights: Dr. Martin Borch Jensen is the co-founder and CSO of https://www.gordian.bio/ (Gordian Biotechnology) Gordian Biotechnology created the first in vivo therapeutic screening platform to radically improve drug development for complex diseases of aging Martin is also involved with an apprenticeship program and a newly announced grant program to catalyze rapid p